Advance Clinical Research and Development with Whole-Body MRI

With AMRA’s MRI-based digital health platform, deep knowledge in disease mechanisms, and experience in drug development and regulatory strategy, you can optimize your study design and advance your clinical trials—confidently and quickly.

Musculoskeletal Research

Get never before possible whole-body muscle and muscle fat measurements —uncompromised quality and precision is changing what’s possible in Neuromuscular Disorders.
Explore Service

Metabolic Research

Move your trials forward quickly and confidently with whole-body MRI and body composition measurements—because accurate data fuels breakthrough therapeutics.
Explore Service

Imaging Analytics and Consulting Services

From protocol planning and study start up, to commercialization, we have a proven track record of facilitating decision-making.
Explore Service

Enhance Your Clinical Trials with AMRA® Researcher

With AMRA® Researcher you get anatomically accurate and precise muscle and fat measurements—it’s time-efficient, cost-effective and regulatory compliant.
  • Rapid whole-body MRI scan
  • Automated image analysis
  • Muscle and fat classification and quantification
  • Secure data transfer
  • Quality-controlled processes
  • 21 CFR Part 11 Compliant
  • Compatible with Philips, GE or Siemens 1.5 and 3T scanners
Get Set Up
Get a Quote
123 +
Imaging Sites Certified
with AMRA’s Protocol
123 +
Publications with
5,000+ citations
41234 +
Quality-Controlled Body Composition Data Sets in the Database
1 +
Subject Matter and
MRI Biomarker Experts

Effortless & Cloud-Based Digital Health

1. Getting Started

Setup & Verification using AMRA® Protocol​
2. Scanning
Rapid MRI
3. Data Transfer

Safe & Secure Image Transfer
4. Analysis

Automated Segmentation,
Quantification & QA

5. Delivery

Body Composition
Spreadsheet

Enhance Clinical Decision-Making With AMRA

Musculoskeletal and Neuromuscular Disorder Research

Whole-Body Muscle Assessment

Enhance musculoskeletal and neuromuscular disorder (NMD) research by leveraging our whole-body MRI protocol and subject matter experts—our MRI protocol is tailored to your area of interest, such as FSHD, DMD, SBMA, LGMD, SMA, Myotonic Dystrophy, Mitochondrial Myopathies and several others.

Our measurements can help you deepen your
understanding of complex diseases and:

  • Complement functional tests with quantitative, objective muscle assessments
  • Visualize individualized disease heterogeneity in patients across various disease stages
  • Detect small and large changes in muscle and fat volumes and tissue quality
  • Align clinical research aims with FDA accepted biomarkers, potentially leading to regulatory approval
Learn more

Metabolic Research

Whole-Body Fat and Muscle Measurements

Accelerate your metabolic disease research and clinical trials to the next level with our Body Composition Profiling Protocol—adaptable to your area of interest, including Liver Disease, NASH, NAFLD, Obesity, Diabetes, Sarcopenia, Cachexia.

Our measurements can help you derisk drug development and:

  • Optimize patient recruitment
  • Detect therapeutic efficacy early
  • Monitor changes in body composition over time
Learn more

Imaging Analytics and Consulting Services

Whether you are designing your first human research study or are launching any phase clinical trial, we offer imaging services to maximize your success and de-risk the drug development lifecycle.

Clinical Protocol Design

Optimize your study from the start with expert input on which of our MR Imaging biomarkers to include and what muscles to evaluate.

Exploratory Biomarkers

Use our imaging biomarkers in novel ways and explore the biomarkers currently in development.

Expert Analytics and Interpretation

Quickly and accurately understand what your MRI measurements mean to gain deeper insights and guide scientific decision making.
Learn more

Research Highlight

An Optimized Clinical Protocol
for Whole-Body MRI in FSHD

AMRA and Fulcrum developed an optimized whole-body magnetic resonance imaging (MRI) protocol and analysis that correlates with clinical outcome assessments in Facioscapulohumeral Muscular Dystrophy (FSHD). The use of MRI and AMRA’s automated measurements can detect small and large changes in muscle—potentially before changes in FSHD-relevant clinical endpoints, providing information earlier on disease severity and progression.
Read More

Our Clinical Research Areas of Interest

Is Your Research Area Not Listed? We can still support you! Contact Us to learn more.

Musculoskeletal

Neuromuscular

Diabetes

Obesity

Cardiovascular

Liver

Sarcopenia

Cachexia

NAFLD/NASH

Cancer

Let's talk

Tell us how you are using MRI for body composition analysis and let’s power the future of medicine together.

    Resources

    Publication

    Webinar

    White Paper

    Webinar

    © 2022 AMRA Medical AB

    By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website.
    Accept & Close

    Book a Meeting